Location: New York, NY
CIK: 0001855655 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $3.918B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 5,269,433 | $530M | 13.5% | $60.72 | +62.4% | COM | 670703107 |
| RVMD | REVOLUTION MEDICINES INC | 6,644,403 | $529M | 13.5% | $38.36 | +70.9% | COM | 76155X100 |
| ACLX | ARCELLX INC | 5,724,016 | $373M | 9.5% | $48.76 | +63.6% | COMMON STOCK | 03940C100 |
| GMAB | GENMAB A/S | 7,039,834 | $217M | 5.5% | $30.73 | — | SPONSORED ADS | 372303206 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,562,154 | $210M | 5.4% | $28.61 | +161.0% | COM | 87650L103 |
| ABVX | ABIVAX SA | 1,417,473 | $191M | 4.9% | $84.90 | — | SPONSORED ADS | 00370M103 |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,544,172 | $189M | 4.8% | $9.20 | +93.4% | COM | 68062P106 |
| PCVX | VAXCYTE INC | 4,068,020 | $188M | 4.8% | $55.45 | -19.3% | COM | 92243G108 |
| XBI | SPDR SERIES TRUST | 1,500,000 | $183M | 4.7% | — | — | Put | 78464A870 |
| — | CIDARA THERAPEUTICS INC | 759,565 | $168M | 4.3% | $95.76 | — | COM NEW | 171757206 |
| EWTX | EDGEWISE THERAPEUTICS INC | 6,541,210 | $162M | 4.1% | $20.10 | -0.1% | COM | 28036F105 |
| SRRK | SCHOLAR ROCK HLDG CORP | 3,062,157 | $135M | 3.4% | $33.97 | +10.4% | COM | 80706P103 |
| URGN | UROGEN PHARMA LTD | 4,473,648 | $105M | 2.7% | $18.17 | +19.4% | COM | M96088105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2,210,774 | $103M | 2.6% | $26.84 | +65.9% | COM | 22663K107 |
| APGE | APOGEE THERAPEUTICS INC | 1,123,243 | $84.78M | 2.2% | $44.51 | +41.5% | COM | 03770N101 |
| EYPT | EYEPOINT INC | 3,691,475 | $67.44M | 1.7% | $12.73 | +11.4% | COM NEW | 30233G209 |
| ERAS | ERASCA INC | 14,159,095 | $52.67M | 1.3% | $2.22 | +26.9% | COM | 29479A108 |
| BBIO | BRIDGEBIO PHARMA INC | 684,277 | $52.34M | 1.3% | $36.37 | +80.5% | COM | 10806X102 |
| ORKA | ORUKA THERAPEUTICS INC | 1,710,316 | $51.84M | 1.3% | $27.86 | 0.0% | COM | 687604108 |
| SYRE | SPYRE THERAPEUTICS INC | 1,467,266 | $48.07M | 1.2% | $26.04 | +0.3% | COM NEW | 00773J202 |
| LXEO | LEXEO THERAPEUTICS INC | 4,763,198 | $47.3M | 1.2% | $9.13 | 0.0% | COM | 52886X107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,443,102 | $44.91M | 1.1% | $17.86 | +53.5% | COM | 92790C104 |
| OCUL | OCULAR THERAPEUTIX INC | 2,935,284 | $35.63M | 0.9% | $7.86 | +54.4% | COM | 67576A100 |
| TERN | TERNS PHARMACEUTICALS INC | 810,286 | $32.74M | 0.8% | $23.11 | 0.0% | COM | 880881107 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,261,749 | $28.32M | 0.7% | $11.74 | — | COM NEW | 107924102 |
| VOR | VOR BIOPHARMA INC | 1,750,000 | $22.89M | 0.6% | $18.62 | 0.0% | COM NEW | 929033207 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 665,251 | $22.63M | 0.6% | $32.21 | 0.0% | COM NEW | 045396207 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,401,217 | $19.64M | 0.5% | $11.51 | 0.0% | COM | 68622P109 |
| IVA | INVENTIVA SA | 4,000,000 | $18.6M | 0.5% | $4.65 | — | ADS | 46124U107 |
| KLRS | KALARIS THERAPEUTICS INC | 700,000 | $5.908M | 0.2% | $6.39 | 0.0% | COM | 482929106 |